Leica Biosystems agreed to buy Statlab Medical Products to broaden Danaher’s diagnostics and anatomical pathology consumables and instruments portfolio. Financial terms were not disclosed, but analysts cited by RBC Capital Markets suggested the deal could top $1 billion, underscoring continued consolidation in pathology tools amid higher clinical and workflow demand.